Search for Clinical Trial Results
Lipidoses - 55 Studies Found
Status | Study |
Completed |
Study Name: Safety and Efficacy of Cerezyme® Infusions Every 4 Weeks Versus Every 2 Weeks in Type 1 Gaucher Disease Condition:
Interventions: Drug: Cerezyme Cerezyme doses of 20-60U/kg every 2 weeks (Q2 Arm) or 40-120 U/kg every 4 weeks (Q4 Arm). |
Completed |
Study Name: A Study of the Efficacy and Safety of Eliglustat Tartrate (Genz-112638) in Type 1 Gaucher Patients Condition:
Interventions: Drug: Eliglustat tartrate Eliglustat (Genz-112638) capsule as single 50 mg dose on Day 1 then eliglustat |
Completed |
Study Name: Evaluation of Antioxidant Activity of Oral Lutein in Preterm and Term Newborn Condition:
Date: 2014-02-17 Interventions:
|
Recruiting |
Study Name: Fat and Sugar Metabolism During Exercise in Patients With Metabolic Myopathy Condition:
|
Withdrawn |
Study Name: Efficacy Study of Daily Pro-Omega LDL for Low-Density Lipoprotein Cholesterol and Triglyceride Reduction Condition: Mixed Hyperlipoproteinemia Date: 2014-02-20 Interventions:
|
Withdrawn |
Study Name: Comparison of the Efficacy and Safety of AtorVastatin mOnotherapy vs. Combination Atorvastatin/Fenofibric Acid Condition: Mixed Hyperlipidemia Date: 2013-10-25 Interventions:
|
Completed |
Study Name: Lipid Efficacy and Safety in Participants With Mixed Hyperlipidemia (MK-0524B-024) Condition: Mixed Hyperlipidemia Date: 2006-02-07 Interventions:
|
Terminated |
Study Name: Carotid B-mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrapib/Atorvastatin to Atorvastatin. Condition: Mixed Hyperlipidemia Date: 2005-08-22 Interventions:
|
Recruiting |
Study Name: Krabbe Disease Global Patient Registry Condition: Krabbe Disease Date: 2016-12-06 |
Recruiting |
Study Name: LYSO-PROVE - Determine the Prognostic Value of Lyso-Gb1 for Monitoring the Progress of Gaucher Disease Condition:
|